Patent Assignment
Reel/Frame 054664/0871
Amended and Restated Patent Security Agreement
Recorded: 2020-12-09
Pages: 35
Assignor
GLOBAL BLOOD THERAPEUTICS, INC.
Executed: 2020-11-20
Assignee
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD, C/O BEAUFORT HOUSE, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties
(49)
Compounds and Uses Thereof for the Modulation of Hemoglobin
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Application:
17/068,306 →
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Application:
15/680,794 →
Publication:
US 2018/0186807
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Dosing Regimens for 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
17/072,979 →
Tablets Comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl) Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
16/900,251 →
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Modulators of Hemoglobin
Modulators of Hemoglobin
Methods of Administering Voxelotor
Application:
62/937,706 →
Methods of Administering Voxelotor
Application:
62/940,154 →
Modulators of Hemoglobin
Application:
63/003,106 →
Process for Preparation of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Application:
63/110,826 →
Modulators of Hemoglobin
Application:
63/003,104 →
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Benzaldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Heteroaryl Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Substituted Aldehyde Compounds and Methods for Their Use in Increasing Tissue Oxygenation
Compounds and uses thereof for the modulation of hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Bicyclic Heteroaryl Compounds and Uses Thereof for the Modulation of Hemoglobin
1:1 Adducts of Sickle Hemoglobin
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Methods of Treatment
Methods of Treatment
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Process for Synthesizing 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)-Pyridin-3-Yl)Methoxy)Benzaldehyde
Tablets Comprising 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Compounds and Uses Thereof for the Modulation of Hemoglobin
Modulators of Hemoglobin
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 3, 2013
From: CHUANG, CHIHYUAN; MORGAN, BRADLEY; WARRINGTON, JEFFREY
To: CYTOKINETICS, INC.
Reel/Frame 030144/0369 →
Assignment of Assignor's Interest
Apr 3, 2013
From: JACOBSON, MATTHEW P.; HUA, LAN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030144/0746 →
Assignment of Assignor's Interest
Apr 3, 2013
From: TANDEM SCIENCES, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030145/0085 →
Assignment of Assignor's Interest
Apr 3, 2013
From: PAULVANNAN, KUMAR
To: TANDEM SCIENCES, INC.
Reel/Frame 030144/0959 →
Assignment of Assignor's Interest
Apr 3, 2013
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 030143/0593 →
Assignment of Assignor's Interest
Mar 27, 2015
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 035272/0422 →
Assignment of Assignor's Interest
Dec 1, 2015
From: METCALF, BRIAN W.; LI, ZHE; XU, QING; GWALTNEY, STEPHEN L., II
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 037182/0007 →
Assignment of Assignor's Interest
Apr 28, 2017
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 042183/0009 →
Assignment of Assignor's Interest
Apr 28, 2017
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 042182/0887 →
Corrective Assignment to Correct the Property Number of 14/776,603 Previously Recorded on Reel 042183 Frame 0009. Assignor(S) Hereby Confirms the Assignment.
May 19, 2017
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 042503/0238 →
Corrective Assignment to Correct the Property Number 14/776,603 Number Should Be 15445878 Previously Recorded at Reel: 042182 Frame: 0887. Assignor(S) Hereby Confirms the Assignment.
May 19, 2017
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 042503/0085 →
Assignment of Assignor's Interest
Jul 31, 2017
From: METCALF, BRIAN W.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 043143/0307 →
Assignment of Assignor's Interest
Jan 11, 2018
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 044603/0447 →
Assignment of Assignor's Interest
Mar 5, 2018
From: YEE, CALVIN W.; LI, ZHE
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 045492/0447 →
Assignment of Assignor's Interest
Mar 15, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 045238/0138 →
Assignment of Assignor's Interest
Mar 15, 2018
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 045238/0111 →
Confirmatory Assignment
May 1, 2018
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 046050/0266 →
Assignment of Assignor's Interest
Feb 20, 2019
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 048382/0583 →
Assignment of Assignor's Interest
Jun 21, 2019
From: XU, QING; LI, ZHE; GWALTNEY, STEPHEN L., II
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 049554/0063 →
Assignment of Assignor's Interest
Jun 24, 2019
From: RAMOS, ELEANOR L.; LEHRER-GRAIWER, JOSHUA ELI; HUTCHALEELAHA, ATHIWAT
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 049569/0052 →
Assignment of Assignor's Interest
Jul 1, 2019
From: LI, ZHE; XU, QING; METCALF, BRIAN W.; YEE, CALVIN W.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 049647/0126 →
Assignment of Assignor's Interest
Jul 1, 2019
From: XU, QING; LI, ZHE
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 049646/0910 →
Assignment of Assignor's Interest
Jul 1, 2019
From: METCALF, BRIAN W.; LI, ZHE; XU, QING; GWALTNEY, STEPHEN L., II
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 049646/0864 →
Assignment of Assignor's Interest
Dec 9, 2019
From: WASHINGTON, CARLA B.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 051220/0349 →
Assignment of Assignor's Interest
Dec 19, 2019
From: SHAM, HING
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 051338/0432 →